1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 18 APRIL 2016

Cancer Drug News 18 APRIL 2016

  • April 2016
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Roche To Make High-Impact Entry Into PD-1/PD-L1 Arena
Industry Brief - Keytruda Gains FDA Breakthrough Therapy Designation For cHL
Industry Brief - FDA Accepts BMS' Opdivo sBLA In cHL
Industry Trend Analysis - Celgene Augments Long-Term Outlook
Industry Brief - FDA Grants Accelerated Approval To Venclexta In CLL
Industry Trend Analysis - AstraZeneca To Benefit From Clovis Setback
Industry Brief - QIAGEN/Mirati To Co-Develop Novel Companion Diagnostic In NSCLC
Industry Brief - Brigatinib Phase III Trial Initiated In ALK-Positive NSCLC Patients
Industry Brief - FDA Accepts Keytruda sBLA In Recurrent/Metastatic HNSCC For Review
Industry Brief - Boehringer Ingelheim Exercises Option on Second Oncology Target Discovery
Industry Brief - Heptares/Kymab Collaborate On Novel Antibody Therapeutics
Industry Brief - Presage Extends Oncology Research Collaboration With Takeda
Industry Brief - MSD/Taiho Enter Pembrolizumab Co-Promotion Deal In Japan
Industry Trend Analysis - Digital Healthcare Transformation Enhanced Through Cognitive Computing
Industry Brief - Leica/Merrimack To Co-Develop HRG Diagnostic For Seribantumab
Industry Trend Analysis - Bioinformatics Will Aid In QIAGEN Returning To Growth

Table Of Contents

Cancer Drug News 18 APRIL 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.